Kerala Ayurveda Limited (KERALAYUR.BO)
INR 418.65
(-0.11%)
INR 418.65
(-0.11%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -22.67 Million | 98.57 Million | -5.01 Million | 74.27 Million | 49.89 Million | 122.91 Million |
| Net Income | -15.27 Million | 42.62 Million | 93.24 Million | -4.16 Million | 60.85 Million | 55.26 Million |
| Depreciation & Amortization | 13.43 Million | 11.07 Million | 12.01 Million | 12.77 Million | 11.43 Million | 9.81 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -35.81 Million | 46.13 Million | -111.16 Million | 62.78 Million | -23.08 Million | 146.14 Million |
| Other non-cash items | 97.65 Million | -1.25 Million | 883.35 Thousand | 2.87 Million | 689.6 Thousand | -88.31 Million |
| Investing Cash Flow | -14.21 Million | -72.18 Million | -19.09 Million | -14.39 Million | -40.25 Million | -29.04 Million |
| Investments in PPE | -11.13 Million | -61.82 Million | -28.49 Million | -10.42 Million | -33.46 Million | -24.62 Million |
| Acquisitions | -3.08 Million | 694 Thousand | - | - | - | 601.64 Thousand |
| Investment purchases | - | -11.81 Million | - | -5.31 Million | -6.98 Million | -19.08 Million |
| Sales/Maturities of investments | - | - | 6.84 Million | 1 Million | - | 20.34 Million |
| Other Investing Activities | -1.44 Million | 768 Thousand | 2.55 Million | 346.12 Thousand | 197.93 Thousand | -6.29 Million |
| Financing Cash Flow | 221.04 Million | -11.35 Million | -132.74 Million | 62.03 Million | 8.49 Million | -115.51 Million |
| Debt repayment | -60.45 Million | -25.06 Million | -212.96 Million | -11.15 Million | -2.76 Million | -91.23 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 281.5 Million | - | - | - | - | - |
| Other Financing Activities | -44.64 Million | 13.71 Million | 80.21 Million | 73.19 Million | 11.26 Million | -24.28 Million |
| Accounts receivables | -28.37 Million | -464 Thousand | -31.5 Million | 3.79 Million | -38.12 Million | -14.56 Million |
| Accounts payables | 2.63 Million | -1.26 Million | 17.69 Million | -5.25 Million | 22.84 Million | 4.99 Million |
| Inventory | -30.06 Million | -5.18 Million | -9.71 Million | 18.26 Million | -12.49 Million | -11.31 Million |
| Other working capital | 19.99 Million | 53.04 Million | -87.64 Million | 45.97 Million | 4.69 Million | 167.02 Million |
| Cash at beginning of period | 31.98 Million | 28.74 Million | 185.59 Million | 63.67 Million | 45.54 Million | 67.19 Million |
| Cash at end of period | 227.94 Million | 43.79 Million | 28.74 Million | 185.59 Million | 63.67 Million | 45.54 Million |
| Capital Expenditure | -11.13 Million | -61.82 Million | -28.49 Million | -10.42 Million | -33.46 Million | -24.62 Million |
| Effect of forex changes on cash | - | -1.00 | -1.00 | 1000.00 | -1.00 | -1.00 |
| Net cash flow / Change in cash | 195.96 Million | 15.04 Million | -156.85 Million | 121.92 Million | 18.13 Million | -21.65 Million |
| Free Cash Flow | -33.8 Million | 36.75 Million | -33.5 Million | 63.85 Million | 16.42 Million | 98.29 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.27 Million | -10.01 Million | -1.28 Million | -3.61 Million | 42.62 Million | 1.79 Million |
| Depreciation & Amortization | 13.43 Million | 3.44 Million | 3.17 Million | 3.28 Million | 11.07 Million | 2.32 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -35.81 Million | - | - | - | 46.13 Million | - |
| Other non-cash items | 97.65 Million | 13.45 Million | -3.17 Million | -3.28 Million | -1.25 Million | -2.32 Million |
| Investing Cash Flow | -14.21 Million | - | - | - | -72.18 Million | - |
| Investments in PPE | -11.13 Million | - | - | - | -61.82 Million | - |
| Acquisitions | -3.08 Million | - | - | - | 694 Thousand | - |
| Investment purchases | - | - | - | - | -11.81 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 768 Thousand | - |
| Financing Cash Flow | 221.04 Million | - | - | - | -11.35 Million | - |
| Debt repayment | -60.45 Million | - | - | - | -25.06 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 281.5 Million | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | 13.71 Million | - |
| Accounts receivables | -28.37 Million | - | - | - | -464 Thousand | - |
| Accounts payables | 2.63 Million | - | - | - | -1.26 Million | - |
| Inventory | -30.06 Million | - | - | - | -5.18 Million | - |
| Other working capital | 19.99 Million | - | - | - | 53.04 Million | - |
| Cash at beginning of period | 31.98 Million | 32.39 Million | 33.68 Million | 31.98 Million | 28.74 Million | 30.18 Million |
| Cash at end of period | 227.94 Million | 39.28 Million | 32.39 Million | -3.61 Million | 43.79 Million | 31.98 Million |
| Capital Expenditure | -11.13 Million | - | - | - | -61.82 Million | - |
| Effect of forex changes on cash | - | - | - | - | -1.00 | - |
| Net cash flow / Change in cash | 195.96 Million | 6.89 Million | -1.28 Million | -35.6 Million | 15.04 Million | 1.79 Million |
| Free Cash Flow | -33.8 Million | 6.89 Million | -1.28 Million | -3.61 Million | 36.75 Million | 1.79 Million |
CIO-PA
STEK
NTR-B
RCOI
BRAXF
3305